FDA targets cancer drugs to be less toxic, more cost effective
FDA urges drug companies to reassess cancer drug dosages for maximum impact and fewer side effects, following study on lung cancer drug
Stay updated with breaking news from Maximum Tolerated Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA urges drug companies to reassess cancer drug dosages for maximum impact and fewer side effects, following study on lung cancer drug
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that through its collaboration agreement with a...
/PRNewswire/ -- Zymedi announced today that the first in human dosage of ZMA001, a monoclonal antibody being developed as a first-in-class treatment for...
A cancer patient says,
Initiation of REVEAL pediatric trial in the U.S.broadens the clinical evaluation of TSHA-102 to female patients 5-8 years old with stage three Ret...